Stockreport

Amgen Looks To Enter Multiple Myeloma Space: Can It Compete? [Seeking Alpha]

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF Summary Amgen announces positive preliminary results using its antibody drug known as AMG 420, which is derived from the anti-BCMA BiTE program. AMG 420 is a dr [Read more]